Azerbaijan vs Türkiye: Tuberculosis patients who tested positive for HIV
Azerbaijan
92 patients
in 2021
Türkiye
85 patients
in 2021
Azerbaijan rank
88th
Türkiye rank
90th
Tuberculosis patients who tested positive for HIV over time
- Azerbaijan
- Türkiye
How they compare
Azerbaijan currently reports 92 patients against 85 patients in Türkiye, a difference of 7 patients.
That makes Azerbaijan's figure about 1.1 times Türkiye's.
The two have swapped places 2 times across 12 shared years of data; in 2010 it was Azerbaijan ahead.
Azerbaijan ranks 88th and Türkiye ranks 90th of 201 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.6 patients | 51.6 patients | 44 patients | Azerbaijan |
| 2020s | 87.5 patients | 84 patients | 3.5 patients | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Azerbaijan or Türkiye?
- Azerbaijan, at 92 patients against 85 patients in Türkiye as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Azerbaijan and Türkiye?
- 7 patients, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Türkiye?
- 12 years are reported by both, from 2010 to 2021.
- How do Azerbaijan and Türkiye rank globally for tuberculosis patients who tested positive for hiv?
- Azerbaijan ranks 88th and Türkiye ranks 90th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.